P2.32 The frequency of myotonic dystrophy type 2 (DM2) and type 1 (DM1) mutations in the population
Tiina Suominen(Tampere University), Bjarne Udd(Folkhälsans Forskningscentrum), Linda L. Bachinski(Baylor College of Medicine), Ralf Krahe(University of Helsinki), S. Auvinen(Central Finland Health Care District), Peter Hackman(Folkhälsans Forskningscentrum), Leena Peltonen(University of Helsinki), C. Angelini(University of Pisa)
Cited by 0
Related Papers
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
|New England Journal of Medicine|1998|759
MELAS: Clinical features, biochemistry, and molecular genetics
|Annals of Neurology|1992|508
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Disruption of the neurexin 1 gene is associated with schizophrenia
|Human Molecular Genetics|2008|485
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484